Rankings
▼
Calendar
JBIO FY 2024 Earnings — Jade Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
JBIO
Jade Biosciences, Inc.
$491M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$282,000
Operating Income
-$75M
Net Income
-$70M
EPS (Diluted)
$-85.26
Cash Flow
Operating Cash Flow
-$71M
Free Cash Flow
-$71M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$80M
Total Liabilities
$4M
Stockholders' Equity
$76M
Cash & Equivalents
$34M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$282,000
-$96,000
-193.8%
Operating Income
-$75M
-$81M
+8.4%
Net Income
-$70M
-$76M
+7.8%
← Q4 2023
All Quarters
Q1 2024 →